Last Close
Mar 16  •  04:00PM ET
3.67
Dollar change
+0.04
Percentage change
1.10
%
Index- P/E- EPS (ttm)-0.27 Insider Own13.70% Shs Outstand41.79M Perf Week7.00%
Market Cap153.51M Forward P/E- EPS next Y-0.28 Insider Trans0.00% Shs Float36.10M Perf Month-3.93%
Enterprise Value161.40M PEG- EPS next Q-0.12 Inst Own45.49% Short Float0.48% Perf Quarter-8.02%
Income-11.21M P/S2.91 EPS this Y-21.30% Inst Trans10.64% Short Ratio1.43 Perf Half Y74.76%
Sales52.84M P/B10.55 EPS next Y12.98% ROA-17.03% Short Interest0.17M Perf YTD4.86%
Book/sh0.35 P/C4.84 EPS next 5Y- ROE-77.99% 52W High4.50 -18.44% Perf Year267.00%
Cash/sh0.76 P/FCF- EPS past 3/5Y25.94% 4.74% ROIC-20.97% 52W Low0.76 385.84% Perf 3Y26.55%
Dividend Est.- EV/EBITDA- Sales past 3/5Y5.89% 13.78% Gross Margin36.02% Volatility9.92% 7.35% Perf 5Y-66.82%
Dividend TTM- EV/Sales3.05 EPS Y/Y TTM58.75% Oper. Margin-12.20% ATR (14)0.29 Perf 10Y103.89%
Dividend Ex-Date- Quick Ratio4.26 Sales Y/Y TTM9.86% Profit Margin-21.22% RSI (14)51.85 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio5.00 EPS Q/Q74.57% SMA204.19% Beta1.60 Target Price6.40
Payout- Debt/Eq2.71 Sales Q/Q34.75% SMA50-1.87% Rel Volume1.90 Prev Close3.63
Employees205 LT Debt/Eq2.68 EarningsMar 10 BMO SMA20025.27% Avg Volume121.73K Price3.67
IPOFeb 22, 1999 Option/ShortYes / Yes EPS/Sales Surpr.45.45% 3.37% Trades Volume223,947 Change1.10%
Date Action Analyst Rating Change Price Target Change
Mar-11-26Upgrade BTIG Research Neutral → Buy $6
Dec-16-25Initiated Roth Capital Buy $6
Nov-14-25Upgrade Citizens JMP Mkt Perform → Mkt Outperform
Nov-12-25Upgrade Citizens JMP Mkt Perform → Mkt Outperform $8
Oct-17-24Initiated BTIG Research Neutral
Jul-14-23Initiated Stephens Overweight $8
May-20-22Initiated Lake Street Buy $12
Apr-02-19Reiterated Dougherty & Company Buy $12 → $9
Mar-11-26 05:40AM
Mar-10-26 03:01PM
07:43AM
07:00AM
Mar-02-26 05:10PM
09:00AM Loading…
Feb-25-26 09:00AM
Feb-18-26 08:00AM
Jan-29-26 08:00AM
Jan-12-26 08:00AM
Dec-03-25 08:00AM
Nov-18-25 07:30AM
Nov-17-25 04:05PM
Nov-06-25 02:06PM
07:20AM
07:00AM
08:00AM Loading…
Oct-27-25 08:00AM
Oct-23-25 08:00AM
Oct-13-25 08:00AM
Sep-29-25 08:00AM
Aug-07-25 04:23PM
04:06PM
04:05PM
04:01PM
Jul-30-25 04:20PM
Jul-28-25 08:00AM
Jul-24-25 04:05PM
May-30-25 09:00AM
May-13-25 11:30AM
08:00AM
May-09-25 03:08AM
07:11AM Loading…
May-08-25 07:11AM
07:00AM
May-07-25 11:43AM
May-01-25 09:00AM
Apr-29-25 08:00AM
Apr-24-25 08:45AM
Mar-25-25 09:00AM
Mar-14-25 03:03AM
Mar-13-25 11:40PM
08:15AM
07:13AM
07:00AM
Feb-27-25 08:00AM
Jan-29-25 07:22AM
Jan-13-25 08:00AM
Jan-06-25 08:00AM
Dec-10-24 10:46PM
Nov-27-24 08:00AM
Nov-12-24 04:05PM
Nov-09-24 06:00AM
Nov-08-24 08:15AM
07:15AM
07:05AM
07:00AM
Nov-07-24 07:12AM
Oct-25-24 08:00AM
Oct-15-24 01:02PM
Oct-09-24 05:58PM
Oct-03-24 12:00PM
Aug-13-24 08:10AM
Aug-08-24 10:00PM
06:30PM
05:24PM
04:10PM
04:05PM
Jul-25-24 07:30AM
Jun-26-24 07:30AM
May-13-24 11:15AM
May-09-24 11:57AM
08:20AM
07:16AM
07:05AM
07:00AM
Apr-25-24 07:30AM
Apr-11-24 07:30AM
Mar-22-24 10:42AM
Mar-21-24 10:25PM
11:53AM
08:15AM
07:11AM
07:00AM
Mar-04-24 07:30AM
Feb-21-24 07:30AM
Jan-22-24 07:30AM
Jan-08-24 07:00AM
Nov-28-23 08:30AM
Nov-10-23 02:08PM
Nov-09-23 08:12AM
07:10AM
07:01AM
07:00AM
Nov-07-23 07:30AM
Oct-26-23 09:40AM
Oct-02-23 07:30AM
Aug-15-23 06:40AM
Aug-11-23 11:33AM
Aug-10-23 05:30PM
04:13PM
04:05PM
Aug-02-23 09:58AM
Apyx Medical Corp. operates as an energy-based medical technology company. The firm engages in developing, manufacturing, and marketing a range of electrosurgical products and technologies, as well as related medical products used by the offices of doctors, surgery centers, and hospitals worldwide. It operates through the following segments: Surgical Aesthetics and Original Equipment Manufacturer (OEM). The Surgical Aesthetics segment consists of the Helium Plasma Technology lines, which include Renuvion and J-Plasma. The OEM segment focuses on designing, development, and manufacturing electrosurgical equipment and medical devices by producing generators, medical devices and related accessories. The company was founded by Andrew Makrides in 1978 and is headquartered in Clearwater, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Roman Shawn DavidChief Operating OfficerJan 27 '26Option Exercise1.8012,00021,60012,000Jan 29 05:21 PM